evt | News | October 13, 2020
evt | News | May 12, 2020
Micro Medical Solutions Begins Pivotal STAND Trial of MicroStent to Treat BTK Arterial Disease
May 12, 2020—Micro Medical Solutions (MMS) announced the first implantation of the company’s MicroStent vascular stent in STAND, the randomized, multicenter pivotal clinical study to support FDA approval of the device to treat arterial disease below the knee.
evt | News | June 23, 2019
Micro Medical Solutions Receives Approval for Pivotal Clinical Trial of MicroStent
June 24, 2019—Micro Medical Solutions (MMS) announced that it has received investigational device exemption (IDE) approval from the FDA to initiate a United States pivotal clinical trial evaluating the safety and efficacy of its MicroStent peripheral vascular stent.
evt | News | November 4, 2018
Micro Medical Solutions' MicroStent With 120-cm Delivery Catheter Receives CE Mark Approval
November 5, 2018—Micro Medical Solutions (MMS) announced that it has received European CE Mark approval for its 4-F–compatible MicroStent 120-cm delivery catheter, as well as MicroStent devices in five lengths and five diameters to meet individual patient needs.
evt | News | June 6, 2018
United States Clinical Trial Begins for Micro Medical Solutions' MicroStent to Treat CLI
June 7, 2018—Micro Medical Solutions announced the completion of the first cases in the United States in the clinical trial evaluating the safety and efficacy of the company's MicroStent, a vascular stent specifically designed to reduce below-the-knee amputations caused by critical limb ischemia (CLI) resulting from peripheral artery disease (PAD).